Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | HALO | KRYS | ||
| Company | Crispr Therapeutics Ag | Halozyme Therapeutic | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 57.00 | 41.10 | 156.62 | ||
| High | 57.10 | 41.66 | 162.34 | ||
| Low | 55.27 | 40.87 | 154.49 | ||
| Last | 55.53 | 41.21 | 161.76 | ||
| Change | -1.53 | +0.35 | +4.82 | ||
| % Change | -2.68% | +0.86% | +3.07% | ||
| Volume | 1,376,700 | 1,281,200 | 359,000 | ||
| 20-Day Average Volume | 1,330,500 | 864,545 | 292,295 | ||
| Previous Close | 57.06 | 40.86 | 156.94 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 56.47 | 39.03 | 163.15 | ||
| 20-Day Raw Stochastic | 27.05% | 88.55% | 48.56% | ||
| 20-Day Relative Strength | 38.63% | 60.08% | 49.98% | ||
| Weighted Alpha | -25.84 | +23.11 | +31.40 | ||
| Today's Opinion | 56% Sell | 72% Buy | 40% Buy | ||
| Previous Opinion | 24% Sell | 64% Buy | 40% Buy | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.79% since 04/30/24 | +8.16% since 04/30/24 | +5.64% since 04/30/24 | ||
| Low | 52.74 on 05/01/24 | 38.29 on 05/01/24 | 144.00 on 05/06/24 | ||
| High | 58.45 on 05/03/24 | 41.66 on 05/07/24 | 164.74 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -11.72% since 04/05/24 | +0.34% since 04/05/24 | -10.14% since 04/05/24 | ||
| Low | 52.73 on 04/30/24 | 37.73 on 04/19/24 | 144.00 on 05/06/24 | ||
| High | 65.24 on 04/09/24 | 41.66 on 05/07/24 | 182.18 on 04/08/24 | ||
| 3-Month | |||||
| %Chg | -15.51% since 02/07/24 | +16.71% since 02/07/24 | +45.48% since 02/07/24 | ||
| Low | 52.73 on 04/30/24 | 34.36 on 02/13/24 | 107.50 on 02/22/24 | ||
| High | 91.10 on 02/22/24 | 42.64 on 03/13/24 | 189.97 on 03/05/24 | ||
| 6-Month | |||||
| %Chg | -5.21% since 11/07/23 | +6.21% since 11/07/23 | +48.34% since 11/07/23 | ||
| Low | 48.55 on 11/13/23 | 33.15 on 02/05/24 | 93.95 on 11/10/23 | ||
| High | 91.10 on 02/22/24 | 42.82 on 12/14/23 | 189.97 on 03/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,843,425 | 5,191,427 | 4,475,143 | ||
| Shares Outstanding, K | 84,883 | 127,054 | 28,515 | ||
| Annual Sales | 371,210,000 | 829,250,000 | 50,700,000 | ||
| Annual Net Income | -153,610,000 | 281,590,000 | 10,930,000 | ||
| Last Quarter Sales | 201,210,000 | 230,040,000 | 42,140,000 | ||
| Last Quarter Net Income | 89,350,000 | 85,390,000 | 8,690,000 | ||
| 60-Month Beta | 1.80 | 1.26 | 0.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.10 on 02/21/24 | 0.82 on 02/20/24 | 0.03 on 05/06/24 | ||
| Latest Earnings Date | 05/13/24 | 05/07/24 | 05/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.65 | 0.00 | ||